The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated https://darrenovlh329323.blogoscience.com/47921121/sildenafil-and-its-maker-and-the-pharmaceutical-sector-a-risky-investment